LGALS3BP and COVID-19: In summary, in our cohort of SARS-CoV-2-infected individuals, 90K protein concentrations were enhanced in sera and reduced in PBMCs, while LGALS3BP mRNA expression in PBMCs from COVID-19 patients remained unaltered as compared to healthy controls.